Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic

Updated on: January 07,2024 10

Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic

Updated on:January 07,2024 10

Measuring tumor infiltrating lymphocytes predicts long term outcomes for type of early breast cancer

byQueen Mary, University of LondonBenefit of radiotherapy in preventing IBE by CPath TIL categories. Credit:The Lancet Digital Health(2024). DOI: 10.1016/S2589-7500(24)00116-XResearc

Updated on: July 11,2024 0

Measuring tumor infiltrating lymphocytes predicts long term outcomes for type of early breast cancer

byQueen Mary, University of LondonBenefit of radiotherapy in preventing IBE by CPath TIL categories. Credit:The Lancet Digital Health(2024). DOI: 10.1016/S2589-7500(24)00116-XResearc

Updated on:July 11,2024 0

Radiation doses from CT scans should be more consistent, say experts

by British Medical JournalCredit: CC0 Public DomainLarge differences in radiation doses used for CT scans are mainly due to how the scanners are used by medical staff rather than differences in t

Updated on: April 07,2024 20

Radiation doses from CT scans should be more consistent, say experts

by British Medical JournalCredit: CC0 Public DomainLarge differences in radiation doses used for CT scans are mainly due to how the scanners are used by medical staff rather than differences in t

Updated on:April 07,2024 20

Study answers questions about long-term survivorship following CAR T treatment

byH. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Axicabtagene cilole

Updated on: August 28,2024 0

Study answers questions about long-term survivorship following CAR T treatment

byH. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Axicabtagene cilole

Updated on:August 28,2024 0

Prostate cancer treatment can wait for most men, study finds

by Carla K. JohnsonThis 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate. A study published by

Updated on: January 23,2024 14

Prostate cancer treatment can wait for most men, study finds

by Carla K. JohnsonThis 1974 microscope image made available by the Centers for Disease Control and Prevention shows changes in cells indicative of adenocarcinoma of the prostate. A study published by

Updated on:January 23,2024 14

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre

Updated on: January 02,2024 9

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre

Updated on:January 02,2024 9

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

by Katie Marquedant,Massachusetts General HospitalDistribution of recurrent melanomas in the study population. Among the 310 recurrent melanomas, 255 (82%) recurred within five years and 285 (92

Updated on: January 02,2024 9

Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence

by Katie Marquedant,Massachusetts General HospitalDistribution of recurrent melanomas in the study population. Among the 310 recurrent melanomas, 255 (82%) recurred within five years and 285 (92

Updated on:January 02,2024 9

Exploring the role of RNA modification in normal hematopoiesis and acute myeloid leukemia pathogenesis

by Cactus CommunicationsThe review sheds light on the role of post-transcriptional RNA modifications in normal hematopoietic development and acute myeloid leukemia, and highlights novel therapeutic ta

Updated on: April 28,2024 0

Exploring the role of RNA modification in normal hematopoiesis and acute myeloid leukemia pathogenesis

by Cactus CommunicationsThe review sheds light on the role of post-transcriptional RNA modifications in normal hematopoietic development and acute myeloid leukemia, and highlights novel therapeutic ta

Updated on:April 28,2024 0

People who live in countryside are less likely to survive cancer

by Rosalind Adam, Peter Murchie And Romi Carriere,The ConversationThe extra load. Credit: Gozha Net, CC BY-SAIt is easy to romanticise about escaping to the country, with its clean air, green sp

Updated on: April 07,2024 12

People who live in countryside are less likely to survive cancer

by Rosalind Adam, Peter Murchie And Romi Carriere,The ConversationThe extra load. Credit: Gozha Net, CC BY-SAIt is easy to romanticise about escaping to the country, with its clean air, green sp

Updated on:April 07,2024 12

Tracking quality of life during prostate cancer treatment

by Anna Williams,Northwestern UniversityKiller T cells surround a cancer cell. Credit: NIHPatients with advanced prostate cancer who received more intensive treatment experienced worse quality o

Updated on: April 01,2024 17

Tracking quality of life during prostate cancer treatment

by Anna Williams,Northwestern UniversityKiller T cells surround a cancer cell. Credit: NIHPatients with advanced prostate cancer who received more intensive treatment experienced worse quality o

Updated on:April 01,2024 17

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on: April 22,2024 20

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog

Updated on:April 22,2024 20

An intelligent knife can tell ovarian cancer and healthy tissue apart. Could it make surgery smarter?

by Katie Roberts,Cancer Research UKTesting the iKnife in the lab. Credit: Cancer Research UKSurgery is a major part of ovarian cancer treatment, but it can be a blunt tool.A big problem for surg

Updated on: April 09,2024 16

An intelligent knife can tell ovarian cancer and healthy tissue apart. Could it make surgery smarter?

by Katie Roberts,Cancer Research UKTesting the iKnife in the lab. Credit: Cancer Research UKSurgery is a major part of ovarian cancer treatment, but it can be a blunt tool.A big problem for surg

Updated on:April 09,2024 16